1 Herceptin Biosimilar Market Overview 1.1 Product Overview and Scope of Herceptin Biosimilar 1.2 Herceptin Biosimilar Segment by Type 1.2.1 Global Herceptin Biosimilar Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Breast Cancer 1.2.3 Colorectal Cancer 1.2.4 Leukemia 1.2.5 Lymphoma 1.2.6 Other 1.3 Herceptin Biosimilar Segment by Application 1.3.1 Global Herceptin Biosimilar Sales Comparison by Application: (2021-2027) 1.3.2 Hospital & Clinics 1.3.3 Oncology Centers 1.3.4 Other 1.4 Global Herceptin Biosimilar Market Size Estimates and Forecasts 1.4.1 Global Herceptin Biosimilar Revenue 2016-2027 1.4.2 Global Herceptin Biosimilar Sales 2016-2027 1.4.3 Herceptin Biosimilar Market Size by Region: 2016 Versus 2021 Versus 2027 2 Herceptin Biosimilar Market Competition by Manufacturers 2.1 Global Herceptin Biosimilar Sales Market Share by Manufacturers (2016-2021) 2.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Herceptin Biosimilar Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Herceptin Biosimilar Manufacturing Sites, Area Served, Product Type 2.5 Herceptin Biosimilar Market Competitive Situation and Trends 2.5.1 Herceptin Biosimilar Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Herceptin Biosimilar Players Market Share by Revenue 2.5.3 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Herceptin Biosimilar Retrospective Market Scenario by Region 3.1 Global Herceptin Biosimilar Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Herceptin Biosimilar Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Herceptin Biosimilar Market Facts & Figures by Country 3.3.1 North America Herceptin Biosimilar Sales by Country 3.3.2 North America Herceptin Biosimilar Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Herceptin Biosimilar Market Facts & Figures by Country 3.4.1 Europe Herceptin Biosimilar Sales by Country 3.4.2 Europe Herceptin Biosimilar Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Herceptin Biosimilar Market Facts & Figures by Region 3.5.1 Asia Pacific Herceptin Biosimilar Sales by Region 3.5.2 Asia Pacific Herceptin Biosimilar Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Herceptin Biosimilar Market Facts & Figures by Country 3.6.1 Latin America Herceptin Biosimilar Sales by Country 3.6.2 Latin America Herceptin Biosimilar Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Herceptin Biosimilar Market Facts & Figures by Country 3.7.1 Middle East and Africa Herceptin Biosimilar Sales by Country 3.7.2 Middle East and Africa Herceptin Biosimilar Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Herceptin Biosimilar Historic Market Analysis by Type 4.1 Global Herceptin Biosimilar Sales Market Share by Type (2016-2021) 4.2 Global Herceptin Biosimilar Revenue Market Share by Type (2016-2021) 4.3 Global Herceptin Biosimilar Price by Type (2016-2021) 5 Global Herceptin Biosimilar Historic Market Analysis by Application 5.1 Global Herceptin Biosimilar Sales Market Share by Application (2016-2021) 5.2 Global Herceptin Biosimilar Revenue Market Share by Application (2016-2021) 5.3 Global Herceptin Biosimilar Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Herceptin Biosimilar Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 AryoGen Biopharma 6.2.1 AryoGen Biopharma Corporation Information 6.2.2 AryoGen Biopharma Description and Business Overview 6.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.2.4 AryoGen Biopharma Herceptin Biosimilar Product Portfolio 6.2.5 AryoGen Biopharma Recent Developments/Updates 6.3 Biocon 6.3.1 Biocon Corporation Information 6.3.2 Biocon Description and Business Overview 6.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Biocon Herceptin Biosimilar Product Portfolio 6.3.5 Biocon Recent Developments/Updates 6.4 Celltrion 6.4.1 Celltrion Corporation Information 6.4.2 Celltrion Description and Business Overview 6.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Celltrion Herceptin Biosimilar Product Portfolio 6.4.5 Celltrion Recent Developments/Updates 6.5 Gedeon Richter 6.5.1 Gedeon Richter Corporation Information 6.5.2 Gedeon Richter Description and Business Overview 6.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Gedeon Richter Herceptin Biosimilar Product Portfolio 6.5.5 Gedeon Richter Recent Developments/Updates 6.6 Genor Biopharma 6.6.1 Genor Biopharma Corporation Information 6.6.2 Genor Biopharma Description and Business Overview 6.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Genor Biopharma Herceptin Biosimilar Product Portfolio 6.6.5 Genor Biopharma Recent Developments/Updates 6.7 Mabion 6.6.1 Mabion Corporation Information 6.6.2 Mabion Description and Business Overview 6.6.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Mabion Herceptin Biosimilar Product Portfolio 6.7.5 Mabion Recent Developments/Updates 6.8 Mylan 6.8.1 Mylan Corporation Information 6.8.2 Mylan Description and Business Overview 6.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Mylan Herceptin Biosimilar Product Portfolio 6.8.5 Mylan Recent Developments/Updates 6.9 Roche 6.9.1 Roche Corporation Information 6.9.2 Roche Description and Business Overview 6.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Roche Herceptin Biosimilar Product Portfolio 6.9.5 Roche Recent Developments/Updates 6.10 The Instituto Vital Brazil 6.10.1 The Instituto Vital Brazil Corporation Information 6.10.2 The Instituto Vital Brazil Description and Business Overview 6.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue and Gross Margin (2016-2021) 6.10.4 The Instituto Vital Brazil Herceptin Biosimilar Product Portfolio 6.10.5 The Instituto Vital Brazil Recent Developments/Updates 7 Herceptin Biosimilar Manufacturing Cost Analysis 7.1 Herceptin Biosimilar Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Herceptin Biosimilar 7.4 Herceptin Biosimilar Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Herceptin Biosimilar Distributors List 8.3 Herceptin Biosimilar Customers 9 Herceptin Biosimilar Market Dynamics 9.1 Herceptin Biosimilar Industry Trends 9.2 Herceptin Biosimilar Growth Drivers 9.3 Herceptin Biosimilar Market Challenges 9.4 Herceptin Biosimilar Market Restraints 10 Global Market Forecast 10.1 Herceptin Biosimilar Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Herceptin Biosimilar by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Herceptin Biosimilar by Type (2022-2027) 10.2 Herceptin Biosimilar Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Herceptin Biosimilar by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Herceptin Biosimilar by Application (2022-2027) 10.3 Herceptin Biosimilar Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Herceptin Biosimilar by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Herceptin Biosimilar by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Herceptin Biosimilar Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Herceptin Biosimilar Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Herceptin Biosimilar Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Herceptin Biosimilar Covered in This Study Table 5. Global Herceptin Biosimilar Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Herceptin Biosimilar Sales Market Share by Manufacturers (2016-2021) Table 7. Global Herceptin Biosimilar Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Herceptin Biosimilar Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Herceptin Biosimilar Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Herceptin Biosimilar Manufacturing Sites and Area Served Table 11. Manufacturers Herceptin Biosimilar Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Herceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Herceptin Biosimilar Sales by Region (2016-2021) & (K Units) Table 16. Global Herceptin Biosimilar Sales Market Share by Region (2016-2021) Table 17. Global Herceptin Biosimilar Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Herceptin Biosimilar Sales by Country (2016-2021) & (K Units) Table 19. North America Herceptin Biosimilar Sales Market Share by Country (2016-2021) Table 20. North America Herceptin Biosimilar Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Herceptin Biosimilar Revenue Market Share by Country (2016-2021) Table 22. Europe Herceptin Biosimilar Sales by Country (2016-2021) & (K Units) Table 23. Europe Herceptin Biosimilar Sales Market Share by Country (2016-2021) Table 24. Europe Herceptin Biosimilar Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Herceptin Biosimilar Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Herceptin Biosimilar Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Herceptin Biosimilar Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Herceptin Biosimilar Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Herceptin Biosimilar Revenue Market Share by Region (2016-2021) Table 30. Latin America Herceptin Biosimilar Sales by Country (2016-2021) & (K Units) Table 31. Latin America Herceptin Biosimilar Sales Market Share by Country (2016-2021) Table 32. Latin America Herceptin Biosimilar Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Herceptin Biosimilar Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Herceptin Biosimilar Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Herceptin Biosimilar Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2016-2021) Table 38. Global Herceptin Biosimilar Sales (K Units) by Type (2016-2021) Table 39. Global Herceptin Biosimilar Sales Market Share by Type (2016-2021) Table 40. Global Herceptin Biosimilar Revenue (Million US$) by Type (2016-2021) Table 41. Global Herceptin Biosimilar Revenue Share by Type (2016-2021) Table 42. Global Herceptin Biosimilar Price (USD/Unit) by Type (2016-2021) Table 43. Global Herceptin Biosimilar Sales (K Units) by Application (2016-2021) Table 44. Global Herceptin Biosimilar Sales Market Share by Application (2016-2021) Table 45. Global Herceptin Biosimilar Revenue (Million US$) by Application (2016-2021) Table 46. Global Herceptin Biosimilar Revenue Share by Application (2016-2021) Table 47. Global Herceptin Biosimilar Price (USD/Unit) by Application (2016-2021) Table 48. Amgen Corporation Information Table 49. Amgen Description and Business Overview Table 50. Amgen Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Amgen Herceptin Biosimilar Product Table 52. Amgen Recent Developments/Updates Table 53. AryoGen Biopharma Corporation Information Table 54. AryoGen Biopharma Description and Business Overview Table 55. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. AryoGen Biopharma Herceptin Biosimilar Product Table 57. AryoGen Biopharma Recent Developments/Updates Table 58. Biocon Corporation Information Table 59. Biocon Description and Business Overview Table 60. Biocon Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Biocon Herceptin Biosimilar Product Table 62. Biocon Recent Developments/Updates Table 63. Celltrion Corporation Information Table 64. Celltrion Description and Business Overview Table 65. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Celltrion Herceptin Biosimilar Product Table 67. Celltrion Recent Developments/Updates Table 68. Gedeon Richter Corporation Information Table 69. Gedeon Richter Description and Business Overview Table 70. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Gedeon Richter Herceptin Biosimilar Product Table 72. Gedeon Richter Recent Developments/Updates Table 73. Genor Biopharma Corporation Information Table 74. Genor Biopharma Description and Business Overview Table 75. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Genor Biopharma Herceptin Biosimilar Product Table 77. Genor Biopharma Recent Developments/Updates Table 78. Mabion Corporation Information Table 79. Mabion Description and Business Overview Table 80. Mabion Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Mabion Herceptin Biosimilar Product Table 82. Mabion Recent Developments/Updates Table 83. Mylan Corporation Information Table 84. Mylan Description and Business Overview Table 85. Mylan Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Mylan Herceptin Biosimilar Product Table 87. Mylan Recent Developments/Updates Table 88. Roche Corporation Information Table 89. Roche Description and Business Overview Table 90. Roche Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Roche Herceptin Biosimilar Product Table 92. Roche Recent Developments/Updates Table 93. The Instituto Vital Brazil Corporation Information Table 94. The Instituto Vital Brazil Description and Business Overview Table 95. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. The Instituto Vital Brazil Herceptin Biosimilar Product Table 97. The Instituto Vital Brazil Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Herceptin Biosimilar Distributors List Table 101. Herceptin Biosimilar Customers List Table 102. Herceptin Biosimilar Market Trends Table 103. Herceptin Biosimilar Growth Drivers Table 104. Herceptin Biosimilar Market Challenges Table 105. Herceptin Biosimilar Market Restraints Table 106. Global Herceptin Biosimilar Sales Forecast by Type (2022-2027) & (K Units) Table 107. Global Herceptin Biosimilar Sales Market Share Forecast by Type (2022-2027) Table 108. Global Herceptin Biosimilar Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Herceptin Biosimilar Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Herceptin Biosimilar Sales Forecast by Application (2022-2027) & (K Units) Table 111. Global Herceptin Biosimilar Sales Market Share Forecast by Application (2022-2027) Table 112. Global Herceptin Biosimilar Revenue Forecast by Application (2022-2027) & (US$ Million) Table 113. Global Herceptin Biosimilar Revenue Market Share Forecast by Application (2022-2027) Table 114. Global Herceptin Biosimilar Sales Forecast by Region (2022-2027) & (K Units) Table 115. Global Herceptin Biosimilar Sales Market Share Forecast by Region (2022-2027) Table 116. Global Herceptin Biosimilar Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Herceptin Biosimilar Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Herceptin Biosimilar Figure 2. Global Herceptin Biosimilar Market Share by Type in 2020 & 2027 Figure 3. Breast Cancer Product Picture Figure 4. Colorectal Cancer Product Picture Figure 5. Leukemia Product Picture Figure 6. Lymphoma Product Picture Figure 7. Other Product Picture Figure 8. Global Herceptin Biosimilar Market Share by Application in 2020 & 2027 Figure 9. Hospital & Clinics Figure 10. Oncology Centers Figure 11. Other Figure 12. Global Herceptin Biosimilar Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Herceptin Biosimilar Market Size 2016-2027 (US$ Million) Figure 14. Global Herceptin Biosimilar Sales 2016-2027 (K Units) Figure 15. Global Herceptin Biosimilar Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Herceptin Biosimilar Sales Share by Manufacturers in 2020 Figure 17. Global Herceptin Biosimilar Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Herceptin Biosimilar Players: Market Share by Revenue in 2020 Figure 19. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Herceptin Biosimilar Sales Market Share by Region (2016-2021) Figure 21. Global Herceptin Biosimilar Sales Market Share by Region in 2020 Figure 22. Global Herceptin Biosimilar Revenue Market Share by Region (2016-2021) Figure 23. Global Herceptin Biosimilar Revenue Market Share by Region in 2020 Figure 24. U.S. Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Herceptin Biosimilar Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Herceptin Biosimilar by Type (2016-2021) Figure 49. Sales Market Share of Herceptin Biosimilar by Application (2016-2021) Figure 50. Sales Market Share of Herceptin Biosimilar by Application in 2020 Figure 51. Revenue Share of Herceptin Biosimilar by Application (2016-2021) Figure 52. Revenue Share of Herceptin Biosimilar by Application in 2020 Figure 53. Manufacturing Cost Structure of Herceptin Biosimilar Figure 54. Manufacturing Process Analysis of Herceptin Biosimilar Figure 55. Herceptin Biosimilar Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Amgen AryoGen Biopharma Biocon Celltrion Gedeon Richter Genor Biopharma Mabion Mylan Roche The Instituto Vital Brazil